EU Ecolabel Criteria Extended to All Cosmetic Products
The EU Ecolabel is awarded to products and services that meet high environmental standards throughout their lifecycle. The European Commission published the Commission Decision (EU) 2021/1870, revising the EU Ecolabel criteria for rinse-off cosmetics and expanding its scope to other cosmetic products.
Picture of Marta Pinto

Marta Pinto

Regulatory Affairs Associate


The EU Ecolabel can be described as a label of environmental excellence. The Regulation (EC) No 66/2010 lays down the rules for establishment and application of the voluntary EU Ecolabel scheme.

According to the European Commission, the EU Ecolabel “promotes the circular economy by encouraging producers to generate less waste and CO2 during the manufacturing process“. Producers, importers and retailers can choose to apply for this label, developing products that are durable, easy to repair and recycle.

Products must comply with a tough set of criteria in order to qualify for the EU Ecolabel. The EU Ecolabel criteria are based on the environmental performance of products, taking into account the latest strategic objectives of the Community in the field of the environment. These criteria are set by a panel of experts from a number of stakeholders (including consumer organizations and industry), considering the whole product lifecycle. This means that this label is awarded to products and services meeting high environmental standards throughout their lifecycle: from raw material extraction, to production, distribution and disposal.

The European Union Ecolabelling Board (EUEB), composed of representatives of the Competent Bodies, contributes to the development and revision of EU Ecolabel criteria and to any review of the implementation of the EU Ecolabel scheme. The Competent Bodies, which are independent and impartial organizations designated by states of the European Economic Area (EEA), are responsible for implementing the EU Ecolabel scheme at the national level. They assess applications and award the EU Ecolabel to products that meet the criteria set for them.


The European Commission published the Commission Decision (EU) 2021/1870 which revises the EU Ecolabel criteria, establishing a new set of criteria for “rinse-off cosmetics” and expanding its scope to other cosmetic products covered by the European Cosmetic Regulation (Regulation (EC) No 1223/2009) and to animal care products. Until now, only rinse-off cosmetic products (like body wash, shampoo and conditioners) could apply for the EU Ecolabel. The revised criteria (“cosmetic products group”) include rinse-off and leave-on products for both private and professional use, adopting the definition of ‘cosmetic product’ set out on the EU Cosmetic Regulation.

The aim of the revised EU Ecolabel criteria is to promote products that have limited impacts in terms of eco-toxicity and biodegradability, which may only contain a limited amount of hazardous substances and that use less packaging, which can be easily recycled. The use of recycled material and refillable packaging is promoted.

The Commission Decision sets out several strict criteria, including requirements for the biodegradability of surfactants and organic ingoing substances, excluded and restricted substances (e.g., substances classified as CMR by the CLP Regulation are totally banned), packaging, sustainable sourcing of palm oil, palm kernel oil and their derivatives, and several other requirements.

Want to know more about the EU Ecolabel? Do not hesitate to contact us at


  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Regulation (EC) No 66/2010 of the European Parliament and of the Council of 25 November 2009 on the EU Ecolabel.
  3. Commission Decision (EU) 2021/1870 of 22 October 2021 establishing the EU Ecolabel criteria for cosmetic products and animal care products.


medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »
cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »